Skip to main content
logo
Sun Pharmaceutical Industries Limited (BOM:524715)
India flag India · Delayed Price · Currency is INR
1,935.25
-3.60 (-0.19%)
At close: Jul 10, 2026

Revenue

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17 Mar '16 Mar '15 Mar '14 Mar '13
India Formulations Revenue
192.90B169.23B
India Formulations Revenue Growth
13.99%13.66%
US Formulations Revenue
168.24B162.40B
US Formulations Revenue Growth
3.60%5.80%
Emerging Markets Revenue
111.87B94.16B
Emerging Markets Revenue Growth
18.80%9.24%
Rest of the World Formulations Revenue
85.68B71.63B
Rest of the World Formulations Revenue Growth
19.63%6.70%
Total Formulations Revenue
558.70B497.42B
Total Formulations Revenue Growth
12.32%9.15%
Active Pharmaceutical Ingredients (API) Revenue
21.85B21.29B
Active Pharmaceutical Ingredients (API) Revenue Growth
2.63%10.97%
Other Segment Revenue
1.65B1.70B
Other Segment Revenue Growth
-2.81%-36.74%
Other Operating Revenue
2.42B5.37B
Other Operating Revenue Growth
-54.96%-27.25%

Key Performance Indicators

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17 Mar '16 Mar '15 Mar '14 Mar '13
Number of Medical Representatives
16.77K15.11K
Number of Medical Representatives Growth
10.97%8.04%
Sales per Medical Representative
11.50M11.20M
Sales per Medical Representative Growth
2.68%5.66%